Our Pricing

What to Expect During Your First Week on Mounjaro

Understanding mounjaro first week side effects uk helps you prepare for your treatment journey with confidence. At Cured Pharmacy, our UK-registered clinical team has supported thousands of patients starting tirzepatide, and we've compiled this comprehensive guide to help you navigate your first seven days on Mounjaro with realistic expectations and practical strategies.

Your First Mounjaro Injection: The 2.5mg Starting Dose

All patients beginning Mounjaro in the UK start with the 2.5mg dose, regardless of their weight or medical history [1]. This cautious approach, mandated by the MHRA licensing terms, allows your body to gradually adapt to tirzepatide's dual GIP/GLP-1 receptor activity whilst minimising the intensity of initial side effects.

The 2.5mg starter dose is specifically designed as a tolerance-building phase rather than a therapeutic dose. Clinical trials showed that patients who began treatment at higher doses experienced significantly more gastrointestinal side effects, which is why the gradual titration schedule exists [1]. You'll remain on this dose for four weeks before your prescriber considers increasing to 5mg, subject to your individual response and tolerability.

Your KwikPen is pre-filled and colour-coded for safety. The 2.5mg pen has a grey base and grey label, making it easily distinguishable from higher doses. Each pen contains four weekly doses, meaning one pen covers your entire first month of treatment. Store it in your refrigerator between 2°C and 8°C, and never freeze it.

Common Side Effects During Week One: What's Normal

Approximately 70-80% of patients starting Mounjaro experience some degree of gastrointestinal side effects during their first week, though most describe them as mild to moderate [2]. The most frequently reported symptoms include nausea (affecting around 30% of patients at the 2.5mg dose), reduced appetite, occasional loose stools, and mild abdominal discomfort.

Nausea typically peaks between days 2 and 4 after your first injection, then gradually diminishes as your body adapts to the medication. Unlike sudden-onset food poisoning, Mounjaro-related nausea tends to be persistent but low-grade—most patients describe it as similar to mild travel sickness rather than severe illness. Eating smaller, more frequent meals and avoiding high-fat foods can significantly reduce this symptom.

Some patients report fatigue or mild headaches during the first week, though these are less common than digestive symptoms. Constipation affects approximately 15% of patients at the starter dose [2]. Staying well-hydrated (aim for 2-2.5 litres of water daily) and maintaining gentle physical activity can help manage these effects.

When to Contact Your Prescriber

Whilst most first-week side effects are expected and manageable, certain symptoms require prompt medical attention. Contact your prescriber immediately if you experience severe, persistent abdominal pain (particularly in the upper abdomen radiating to your back), repeated vomiting that prevents you keeping fluids down, signs of pancreatitis, or symptoms of gallbladder problems. These serious side effects are rare but require clinical assessment.

Similarly, if you develop signs of an allergic reaction—such as widespread rash, facial swelling, difficulty breathing, or rapid heartbeat—seek emergency medical care. Your UK prescriber can provide guidance on managing milder symptoms and will determine whether any adjustments to your treatment plan are necessary.

Appetite Changes and Early Weight Loss in Week One

One of the most noticeable effects during your first week on Mounjaro is a marked reduction in appetite. Tirzepatide works by activating GLP-1 and GIP receptors in your brain's appetite control centres, leading to earlier satiety and reduced food cravings [3]. Many patients report feeling satisfied after eating significantly smaller portions than usual, and some experience a complete absence of hunger between meals.

This appetite suppression is not merely psychological—it's a direct pharmacological effect of how tirzepatide slows gastric emptying and influences hunger hormones. You may find that foods you previously enjoyed seem less appealing, or that you simply forget to eat at your usual mealtimes. Whilst this is therapeutically beneficial, it's important to ensure you're still consuming adequate nutrition and protein.

Weight loss during the first week is typically modest—most patients lose between 0.5kg and 2kg, with much of this representing water weight and reduced food volume in the digestive system rather than fat loss [1]. The 2.5mg starter dose is sub-therapeutic for weight loss, so dramatic results at this stage aren't expected. Sustainable fat loss accelerates as you progress through higher doses over the coming months.

Practical Tips for Managing Your First Week on Mounjaro

Timing your first injection can influence your experience. Many UK pharmacists recommend administering your first dose on a Friday evening or Saturday morning, giving you the weekend to adjust without work commitments. Choose a consistent day and time each week—Mounjaro has a long half-life, so slight variations of a day or two won't significantly impact efficacy, but routine helps with adherence.

Dietary modifications can substantially reduce side effects. Focus on bland, easily digestible foods during week one: porridge, plain chicken, steamed vegetables, bananas, and wholegrain toast. Avoid greasy takeaways, spicy curries, rich sauces, and excessive dairy, as these exacerbate nausea. Eat slowly and stop when you feel comfortably satisfied rather than full—overeating triggers more pronounced discomfort on tirzepatide.

Hydration is critical but requires strategy. Sip water consistently throughout the day rather than drinking large volumes at once, which can worsen nausea. Ginger tea, peppermint tea, and diluted squash can be more tolerable than plain water if you're feeling queasy. Avoid carbonated drinks during the first week, as they increase bloating and abdominal discomfort.

Injection Technique for Optimal Comfort

Proper injection technique minimises discomfort and ensures optimal medication absorption. Rotate between your abdomen (at least 5cm away from your navel), outer thighs, and upper arms to prevent lipohypertrophy (fatty lumps under the skin). The abdomen typically causes the least discomfort and is most convenient for self-administration.

Allow the pen to reach room temperature for 30 minutes before injecting—cold medication stings more. Pinch a fold of skin, insert the needle at a 90-degree angle, press the button firmly until you hear a click, and hold for 10 seconds to ensure the full dose is delivered. A tiny drop of blood or clear fluid at the injection site is normal and doesn't indicate a problem.

Comparing Your First Week: Mounjaro vs Other GLP-1 Treatments

Patients often ask how the first week on Mounjaro compares to other injectable weight loss medications available in the UK. Wegovy (semaglutide) and Saxenda (liraglutide) share similar side effect profiles, as all three are GLP-1 receptor agonists, but there are notable differences in onset and intensity.

Saxenda requires daily injections starting at 0.6mg and gradually increasing over five weeks, which some patients find provides a gentler introduction with more controllable side effects. However, the daily injection schedule is less convenient than Mounjaro's once-weekly administration. Wegovy, like Mounjaro, is injected weekly, but clinical comparisons suggest tirzepatide's dual receptor mechanism produces greater weight loss outcomes at equivalent timeframes [4].

The SURPASS-2 head-to-head trial directly compared tirzepatide to semaglutide and found that patients on the highest tirzepatide dose (15mg) achieved an average 12.4kg weight loss at 40 weeks compared to 6.2kg with semaglutide 1mg [4]. However, both medications showed similar tolerability profiles during the initial titration phases, meaning your first-week experience on either treatment would likely be comparable.

What Happens After Week One: Your Mounjaro Journey Ahead

By the end of your first week, most patients notice that initial side effects have either resolved completely or reduced significantly in intensity. Your body begins adapting to tirzepatide's presence, and the gastrointestinal symptoms that dominated days 2-4 typically settle into a manageable background pattern. Appetite suppression, however, remains consistent—this is the therapeutic effect you want to maintain.

You'll continue on the 2.5mg dose for a total of four weeks before your prescriber assesses whether to increase to 5mg. This gradual titration continues monthly, potentially progressing through 7.5mg, 10mg, 12.5mg, and ultimately 15mg, depending on your individual response and tolerability. Each dose increase may trigger a brief return of mild side effects for 3-5 days as your body readjusts.

Clinical trials demonstrate that maximal weight loss typically occurs between months 8 and 12 of treatment, with patients on the 15mg maintenance dose achieving an average 22.5% reduction in body weight [1]. Your first week is merely the foundation of this longer journey. At Cured Pharmacy, our UK prescribers provide ongoing support throughout your treatment, adjusting doses based on your progress and managing any emerging concerns. Mounjaro is available from £135.00 per month, subject to prescriber approval following your free online consultation.

Long-Term Success Strategies

Sustainable weight loss on Mounjaro requires more than medication alone. Use this first week to establish healthy habits: plan balanced meals rich in protein and vegetables, incorporate regular physical activity (even gentle walks count), and track your progress through measurements rather than obsessing over daily scale fluctuations. The medication provides a powerful tool, but your behavioural changes determine long-term success.

Join support communities, work with a dietitian if possible, and maintain regular check-ins with your prescriber. Patients who combine Mounjaro with structured lifestyle modifications achieve significantly better outcomes than those relying on medication alone. Your first week is about adjustment and learning; the months ahead are where transformative change occurs.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Frias, J. P., et al. (2021). Efficacy and safety of tirzepatide in type 2 diabetes: The SURPASS clinical trial programme. Diabetes, Obesity and Metabolism, 23(S3), 5–13. https://doi.org/10.1111/dom.14459
3. Nauck, M. A., & D'Alessio, D. A. (2022). Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction. Cardiovascular Diabetology, 21(1), 169. https://doi.org/10.1186/s12933-022-01604-7
4. Frías, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and the experiences described are based on clinical trial data and common patient reports. Mounjaro is a prescription-only medicine and must be prescribed by a qualified UK healthcare professional following appropriate clinical assessment.